| Tau post-translational modifications: Dynamic transformers of tau function, degradation, and aggregation C Alquezar, S Arya, AW Kao Frontiers in Neurology, 1826, 2021 | 208 | 2021 |
| Targeting TDP-43 phosphorylation by Casein Kinase-1δ inhibitors: a novel strategy for the treatment of frontotemporal dementia C Alquezar, IG Salado, A de la Encarnación, DI Pérez, F Moreno, C Gil, ... Molecular neurodegeneration 11 (1), 36, 2016 | 80 | 2016 |
| Role of Resveratrol and Selenium on Oxidative Stress and Expression of Antioxidant and Anti-Aging Genes in Immortalized Lymphocytes from Alzheimer’s Disease Patients M Cosín-Tomàs, J Senserrich, M Arumí-Planas, C Alquézar, M Pallàs, ... Nutrients 11 (8), 1764, 2019 | 78 | 2019 |
| A Comprehensive Resource for Induced Pluripotent Stem Cells from Patients with Primary Tauopathies CM Karch, AW Kao, A Karydas, K Onanuga, R Martinez, A Argouarch, ... Stem cell reports 13 (5), 939-955, 2019 | 70 | 2019 |
| Genetically encoded, pH-sensitive mTFP1 biosensor for probing lysosomal pH MY Chin, AR Patwardhan, KH Ang, AL Wang, C Alquezar, M Welch, ... ACS sensors 6 (6), 2168-2180, 2021 | 43 | 2021 |
| Progranulin deficiency induces overactivation of WNT5A expression via TNF-α/NF-κB pathway in peripheral cells from frontotemporal dementia-linked granulin mutation carriers C Alquézar, A de la Encarnación, F Moreno, AL de Munain, ... Journal of Psychiatry and Neuroscience 41 (4), 225-239, 2016 | 38 | 2016 |
| Heavy metals contaminating the environment of a progressive supranuclear palsy cluster induce tau accumulation and cell death in cultured neurons C Alquezar, JB Felix, E McCandlish, BT Buckley, D Caparros-Lefebvre, ... Scientific Reports 10 (1), 1-12, 2020 | 33 | 2020 |
| PGRN haploinsufficiency increased Wnt5a signaling in peripheral cells from frontotemporal lobar degeneration-progranulin mutation carriers C Alquézar, N Esteras, A de la Encarnación, A Alzualde, F Moreno, ... Neurobiology of aging 35 (4), 886-898, 2014 | 33 | 2014 |
| Altered cell cycle‐related gene expression in brain and lymphocytes from a transgenic mouse model of Alzheimer’s disease [amyloid precursor protein/presenilin 1 (PS1)] N Esteras, F Bartolomé, C Alquézar, D Antequera, U Munoz, E Carro, ... European Journal of Neuroscience 36 (5), 2609-2618, 2012 | 31 | 2012 |
| Increasing progranulin levels and blockade of the ERK1/2 pathway: upstream and downstream strategies for the treatment of progranulin deficient frontotemporal dementia C Alquezar, N Esteras, A de la Encarnación, F Moreno, AL de Munain, ... European Neuropsychopharmacology 25 (3), 386-403, 2015 | 30 | 2015 |
| Control of cell adhesion and migration by podocalyxin. Implication of Rac1 and Cdc42 D Fernández, A Horrillo, C Alquezar, C González-Manchón, R Parrilla, ... Biochemical and biophysical research communications 432 (2), 302-307, 2013 | 30 | 2013 |
| Calmodulin levels in blood cells as a potential biomarker of Alzheimer’s disease N Esteras, C Alquézar, A De la Encarnación, A Villarejo, ... Alzheimer's research & therapy 5 (6), 1-10, 2013 | 27 | 2013 |
| Alteration in cell cycle-related proteins in lymphoblasts from carriers of the c. 709-1G> A PGRN mutation associated with FTLD-TDP dementia C Alquezar, N Esteras, F Bartolomé, JJ Merino, A Alzualde, AL de Munain, ... Neurobiology of aging 33 (2), 429. e7-429. e20, 2012 | 27 | 2012 |
| G1/S Cell Cycle Checkpoint Dysfunction in Lymphoblasts from Sporadic Parkinson’s Disease Patients N Esteras, C Alquézar, F Bartolomé, A De la Encarnación, ... Molecular neurobiology 52, 386-398, 2015 | 26 | 2015 |
| Downregulation of extracellular signal-regulated kinase 1/2 activity by calmodulin KII modulates p21Cip1 levels and survival of immortalized lymphocytes from Alzheimer’s … N Esteras, C Alquézar, F Bermejo-Pareja, E Bialopiotrowicz, U Wojda, ... Neurobiology of aging 34 (4), 1090-1100, 2013 | 26 | 2013 |
| TSC1 loss increases risk for tauopathy by inducing tau acetylation and preventing tau clearance via chaperone-mediated autophagy C Alquezar, KM Schoch, EG Geier, EM Ramos, A Scrivo, KH Li, ... Science Advances 7 (45), eabg3897, 2021 | 24 | 2021 |
| Lymphocytes in Alzheimer’s disease pathology: Altered signaling pathways N Esteras, C Alquézar, A de la Encarnación Current Alzheimer Research 13 (4), 439-449, 2016 | 24 | 2016 |
| Altered calmodulin degradation and signaling in non-neuronal cells from Alzheimer’s disease patients N Esteras, Ú Muñoz, C Alquézar, F Bartolomé, F Bermejo-Pareja, ... Current Alzheimer Research 9 (3), 267-277, 2012 | 24 | 2012 |
| Systematic evaluation of magnetic resonance imaging and spectroscopy techniques for imaging a transgenic model of Alzheimer's disease (AβPP/PS1) N Esteras, C Alquezar, F Bartolome, D Antequera, L Barrios, E Carro, ... Journal of Alzheimer's Disease 30 (2), 337-353, 2012 | 23 | 2012 |
| Targeting cyclin D3/CDK 6 activity for treatment of Parkinson's disease C Alquézar, E Barrio, N Esteras, A De la Encarnación, F Bartolomé, ... Journal of neurochemistry 133 (6), 886-897, 2015 | 22 | 2015 |
